Back to top

TD Cowen Sticks to Its Buy Rating for Avita Medical (RCEL)

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Avita Medical (RCEL – Research Report). The company’s shares ope...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Avita Medical Inc. (RCEL)